{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:34:30Z","timestamp":1774049670138,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to investigate the knowledge, attitude, and decisional conflict regarding biologic treatments among patients with inflammatory bowel disease (IBD) in China.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study included IBD patients recruited at the authors\u2019 hospital between July 2023 and January 2024. Data were collected using a self-administered questionnaire covering demographic characteristics, knowledge, attitude, and decisional conflict (measured by the Decisional Conflict Scale).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 405 IBD patients participated, with 45.9% aged 30\u201349\u202fyears and 64% male. The average knowledge score was 6.03\u202f\u00b1\u202f2.98 (possible range: 0\u201311), and the average attitude score was 24.36\u202f\u00b1\u202f3.32 (possible range: 8\u201340). Among them, 60 (14.8%) patients exhibited significant decisional conflict. Spearman correlation analysis revealed a positive association between knowledge and attitude scores (<jats:italic>r<\/jats:italic>\u202f=\u202f0.554, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001). Multivariate analysis revealed that being \u2265 50\u202fyears old, having ulcerative colitis, never having used biologics, and experiencing significant decisional conflict were associated with lower knowledge scores. Higher knowledge scores, a monthly income between 10,000\u201320,000 RMB, never having used biologics, and significant decisional conflict were associated with lower attitude.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Older age, ulcerative colitis, lack of prior biologic use, and decisional conflict were associated with lower knowledge and lower attitude toward biologics among IBD patients. Targeted educational interventions may help reduce decisional conflict and improve patients\u2019 attitudes toward biologic therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1604851","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:27:06Z","timestamp":1759987626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Knowledge, and attitude, and decisional conflict regarding biologics among patients with inflammatory bowel disease: a cross-sectional study"],"prefix":"10.3389","volume":"12","author":[{"given":"Qianqian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenmei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biomedicines12030689","article-title":"Crohn's disease and ulcerative colitis: from pathophysiology to novel therapeutic approaches","volume":"12","author":"Long","year":"2024","journal-title":"Biomedicine"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ibd\/izad061","article-title":"Prevalence of Extraintestinal manifestations in inflammatory bowel disease: a systematic review and Meta-analysis","volume":"30","author":"Kilic","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/ibd\/izae064","article-title":"Exploring the predictive value of gut microbiome signatures for therapy intensification in patients with inflammatory bowel disease: a 10-year follow-up study","volume":"30","author":"Al Radi","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0001421","DOI":"10.1128\/iai.00014-21","article-title":"Cross talk between gut microbiota and intestinal mucosal immunity in the development of ulcerative colitis","volume":"89","author":"Zou","year":"2021","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fphar.2019.00279","article-title":"Biological therapies in immune-mediated inflammatory diseases: can Biosimilars reduce access inequities?","volume":"10","author":"Baumgart","year":"2019","journal-title":"Front Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.3390\/jpm13060947","article-title":"Quality of life (QoL) in patients with chronic inflammatory bowel diseases: how much better with biological drugs?","volume":"13","author":"Bellone","year":"2023","journal-title":"J Pers Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e41120","DOI":"10.7759\/cureus.41120","article-title":"Advancements in inflammatory bowel disease: a narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation","volume":"15","author":"Muzammil","year":"2023","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/ibd\/izaa311","article-title":"Assessing patient decision-making on biologic and small-molecule therapies in inflammatory bowel diseases: insights from a conjoint analysis in the United States, Canada, and the United Kingdom","volume":"27","author":"Patel","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3748\/wjg.v28.i26.3092","article-title":"Shared decision-making in the management of patients with inflammatory bowel disease","volume":"28","author":"Song","year":"2022","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"otac009","DOI":"10.1093\/crocol\/otac009","article-title":"Clinical outcome assessments in pediatric patients with ulcerative colitis and Crohn's disease receiving biologics: a retrospective cohort study","volume":"4","author":"Hunter","year":"2022","journal-title":"Crohn's & colitis 360"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3109\/00365521.2010.490595","article-title":"Perceptions of medication safety among patients with inflammatory bowel disease","volume":"45","author":"Cullen","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.21037\/apm.2020.03.01","article-title":"Impact of knowledge, attitude, and practice (KAP)-based rehabilitation education on the KAP of patients with intervertebral disc herniation","volume":"9","author":"Wang","year":"2020","journal-title":"Ann Palliat Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.3748\/wjg.v29.i43.5818","article-title":"Knowledge, attitude, and practice of patients living with inflammatory bowel disease: a cross-sectional study","volume":"29","author":"Shao","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4103\/jehp.jehp_1543_20","article-title":"Reconstruction of individual, social, and professional life: self-management experience of patients with inflammatory bowel disease","volume":"10","author":"Mohsenizadeh","year":"2021","journal-title":"J Educ Health Promot"},{"key":"ref17","first-page":"244","article-title":"Inflammatory bowel disease group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus on biological agents in treating patients with inflammatory bowel disease","volume":"11","year":"2021","journal-title":"Chin J Dig"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.dld.2023.01.155","article-title":"Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology","volume":"55","author":"Macaluso","year":"2023","journal-title":"Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.breast.2020.12.001","article-title":"Decisional conflict in breast cancer patients considering immediate breast reconstruction","volume":"55","author":"Ter Stege","year":"2021","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.identj.2021.05.004","article-title":"Knowledge and attitude of dentists towards obstructive sleep apnea","volume":"72","author":"Alzahrani","year":"2022","journal-title":"Int Dent J"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s10620-022-07507-7","article-title":"A short knowledge assessment tool is valid and acceptable for adults with inflammatory bowel disease","volume":"67","author":"Buerkle","year":"2022","journal-title":"Dig Dis Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/ibd.21464","article-title":"Assessment of knowledge in adolescents with inflammatory bowel disease using a novel transition tool","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/apa.15211","article-title":"Knowledge of disease and self-management of adolescents with inflammatory bowel diseases","volume":"109","author":"Krauthammer","year":"2020","journal-title":"Acta Paediatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2522\/ptj.2011.91.5.826.1","article-title":"Physical therapy","volume":"91","author":"Breuker","year":"2011","journal-title":"Phys Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/mcg.0000000000001283","article-title":"Comparison of disease-related knowledge of patients with inflammatory bowel disease between the west and the east using an updated questionnaire (IBD-KNOW)","volume":"54","author":"Kim","year":"2020","journal-title":"J Clin Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1604851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T05:27:08Z","timestamp":1759987628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1604851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":25,"alternative-id":["10.3389\/fmed.2025.1604851"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1604851","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"article-number":"1604851"}}